<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
</head><body>
<span style="position:absolute; border: gray 1px solid; left:0px; top:50px; width:612px; height:792px;"></span>
<div style="position:absolute; top:50px;"><a name="1">Page 1</a></div>
<div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:108px; width:501px; height:302px;"><span style="font-family: Arial,Bold; font-size:10px">Methods: </span><span style="font-family: Arial; font-size:10px">We conducted a systematic review and meta-analysis of the effect of a low GI/GL diet on 
<br>body  weight.  We  searched  databases  Medline,  EMBASE,  and  Cochrane  Library  (through  June  26 
<br>2014).  We  selected  randomized  controlled  trials  ≥12  weeks  in  duration  reporting  body  weight.  The 
<br>intervention diet was either low GI or GL compared against high GI/GL diets. We extracted all relevant 
<br>data, which was pooled using the generic inverse variance method using random effects models and 
<br>expressed as mean differences (MD)  with 95%  CIs. Heterogeneity  was  assessed by the Cochran Q 
<br>statistic  and  quantified  by  the  I</span><span style="font-family: Arial; font-size:6px">2  </span><span style="font-family: Arial; font-size:10px">statistic.  Study  quality  was  assessed  using  the  Heyland 
<br>Methodological  Quality  Score  (MQS)</span><span style="font-family: Arial; font-size:6px">1</span><span style="font-family: Arial; font-size:10px">  and  to  assess  risk  of  bias  the  Cochrane  Collaboration  Risk of 
<br>Bias Tool</span><span style="font-family: Arial; font-size:6px">2</span><span style="font-family: Arial; font-size:10px"> was used.  
<br></span><span style="font-family: Arial,Bold; font-size:10px">Results:</span><span style="font-family: Arial; font-size:10px">  Eligibility criteria were met by 28 RCTs (31 comparisons) including 2,778 participants who 
<br>were healthy (n=43), had type 2 diabetesmellitus (n=693), was overweight or obese (n=2382), or had 
<br>the metabolic syndrome (n=448).  Low GI/GL diets did not significantly decrease body weight 
<br>compared to high GI/GL diets (MD= -0.44kg (95% Cis -0.92, 0.05 kg)) with evidence of substantial 
<br>heterogeneity (p&lt;0.05). Most of the trials were of short duration (&lt;12 weeks) and of poor quality 
<br>(MQS&lt;8).  
<br></span><span style="font-family: Arial,Bold; font-size:10px">Limitations:</span><span style="font-family: Arial; font-size:10px"> Most of the trials were of short duration (&lt;12 weeks) and of poor quality (MQS&lt;8) with 
<br>substantial unexplained inter-study heterogeneity.  
<br></span><span style="font-family: Arial,Bold; font-size:10px">Conclusion: </span><span style="font-family: Arial; font-size:10px">Low GI/GL diets do not lead to significantly more weight loss than high GI/GL diets. To 
<br>address the sources of uncertainty, there is a need for larger, longer, higher quality trials.  
<br></span><span style="font-family: Arial,Bold; font-size:10px">Funding:</span><span style="font-family: Arial; font-size:10px"> The Canadian Institutes of Health Research (funding reference number, 129920) through 
<br>the Canada-wide Human Nutrition Trialists’ Network (NTN) and PSI foundation.  
<br> 
<br> 
<br></span><span style="font-family: Arial,Bold; font-size:11px">21.  Starch Intake and Incidence of Type 2 Diabetes: A Systematic Review and Meta-
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:84px; top:413px; width:188px; height:11px;"><span style="font-family: Arial,Bold; font-size:11px">Analysis of Prospective Cohorts 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:427px; width:501px; height:346px;"><span style="font-family: Arial,Bold; font-size:11px">(Sandhya Pudaruth) 
<br></span><span style="font-family: Arial,Bold; font-size:7px"> 
<br></span><span style="font-family: Arial,Italic; font-size:10px">Sandhya Sahye-Pudaruth</span><span style="font-family: Arial,Italic; font-size:6px">1, 2, &amp; 3,</span><span style="font-family: Arial,Italic; font-size:10px"> Sonia Blanco Mejia</span><span style="font-family: Arial,Italic; font-size:6px">1, 2, </span><span style="font-family: Arial,Italic; font-size:10px">David Jenkins</span><span style="font-family: Arial,Italic; font-size:6px">1, 2, 3,4, 5, 6, &amp; 7,</span><span style="font-family: Arial,Italic; font-size:10px"> Ann Fox </span><span style="font-family: Arial,Italic; font-size:6px">1, 3,</span><span style="font-family: Arial,Italic; font-size:10px"> John L. 
<br>Sievenpiper</span><span style="font-family: Arial,Italic; font-size:6px">1, 2, 4, &amp; 5 </span><span style="font-family: Arial,Italic; font-size:10px"> 
<br></span><span style="font-family: Arial,Italic; font-size:6px">1</span><span style="font-family: Arial,Italic; font-size:10px">Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Toronto, Canada 
<br></span><span style="font-family: Arial,Italic; font-size:6px">2</span><span style="font-family: Arial,Italic; font-size:10px">Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Risk Factor Modification Center, St. 
<br>Michael’s Hospital, Toronto, Canada,  </span><span style="font-family: Arial,Italic; font-size:6px">3</span><span style="font-family: Arial,Italic; font-size:10px">Dalla Lana School Public Health, University of Toronto, 
<br>Toronto, Canada  </span><span style="font-family: Arial,Italic; font-size:6px">4</span><span style="font-family: Arial,Italic; font-size:10px">Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, 
<br>Toronto, Canada, </span><span style="font-family: Arial,Italic; font-size:6px">5</span><span style="font-family: Arial,Italic; font-size:10px">Keenan Research Center of the Li Ka Shing  Knowledge Institute, St. Michael’s 
<br>Hospital, Toronto, Canada, </span><span style="font-family: Arial,Italic; font-size:6px">6</span><span style="font-family: Arial,Italic; font-size:10px">Division of Endocrinology and Metabolism,   St. Michael’s Hospital, 
<br>Toronto, Canada, </span><span style="font-family: Arial,Italic; font-size:6px">7</span><span style="font-family: Arial,Italic; font-size:10px">Department of Medicine Faculty of Medicine, University of Toronto, Toronto, 
<br>Canada. E-mail: sandhya.sahye.pudaruth@utoronto.ca 
<br></span><span style="font-family: Arial,Bold; font-size:7px"> 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Objective</span><span style="font-family: Arial; font-size:10px">: To investigate the association between starch intake and incidence of type 2 diabetes. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Methods:</span><span style="font-family: Arial; font-size:10px"> MEDLINE, EMBASE, and The Cochrane Registry were searched through February 10, 
<br></span><span style="font-family: Arial; font-size:10px">2015.  Prospective cohort studies in humans investigating the association between starch intake and 
<br></span><span style="font-family: Arial; font-size:10px">incidence of type 2 diabetes were included. Full article review and data extraction were conducted by 
<br></span><span style="font-family: Arial; font-size:10px">two independent investigators.  Pool analyses were conducted using the generic inverse variance 
<br>method with random effects models.  Interstudy heterogeneity was assessed using the Cochran Q (</span><span style="font-family: Arial,Italic; font-size:10px">X</span><span style="font-family: Arial,Italic; font-size:6px">2</span><span style="font-family: Arial,Italic; font-size:10px">)</span><span style="font-family: Arial; font-size:10px"> 
<br></span><span style="font-family: Arial; font-size:10px">statistic and quantified by I</span><span style="font-family: Arial; font-size:6px">2</span><span style="font-family: Arial; font-size:10px"> statistic. 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Results:</span><span style="font-family: Arial; font-size:10px"> 12 prospective cohort studies were included with a total of 137,840 otherwise healthy and 
<br></span><span style="font-family: Arial; font-size:10px">non-diabetic participants. The risk ratio for incident type 2 diabetes comparing the highest to the 
<br></span><span style="font-family: Arial; font-size:10px">lowest quintile of starch intake was 0.90 g (95% CI, 0.81, 1.00 g), I² = 0%, P =0.04.  </span><span style="font-family: Arial,Bold; font-size:10px"> 
<br></span><span style="font-family: Arial,Bold; font-size:10px">Conclusion:</span><span style="font-family: Arial; font-size:10px"> Our meta-analysis found that starch, regardless of the amount consumed was related 
<br>with a reduced risk of type 2 diabetes.  Our evidence is supported by prospective cohort studies only, 
<br>and more research clarifying the mechanisms by which starch reduces the risk for type 2 diabetes 
<br>should be explored.   
<br> 
<br></span></div><div style="position:absolute; border: textbox 1px solid; writing-mode:lr-tb; left:56px; top:781px; width:13px; height:24px;"><span style="font-family: ABCDEE+Calibri; font-size:11px">78 
<br> 
<br></span></div><span style="position:absolute; border: black 1px solid; left:55px; top:448px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:460px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:473px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:486px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:498px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:511px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:524px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:536px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:549px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:55px; top:562px; width:501px; height:12px;"></span>
<span style="position:absolute; border: black 1px solid; left:138px; top:573px; width:186px; height:0px;"></span>
<div style="position:absolute; top:0px;">Page: <a href="#1">1</a></div>
</body></html>
